Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Liraglutide (Saxenda®) (GLP1s should all be prescribed by brand name)	TA664 - Liraglutide for managing overweight and obesity	The use of Liraglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place. Prescribe by brand (Saxenda®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes.
Lisdexamfetamine		ESCAs and additional advice in relation to age of patient and CCG
Lofexidine		Hospital only
Lomitapide		Homozygous familial hypercholesterolaemia - hospital only
Lomustine capsules
Loprazolam injection
Lorazepam
Lorazepam injection
Lorlatinib (Lorviqua®)	TA628 - Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer
L-ornithine L-aspartate 5gm/10ml injection

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.